These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al]. Miederer SE Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976 [No Abstract] [Full Text] [Related]
5. Effect of omeprazole on serum gastrin levels: influence of age and sex. Koop H; Naumann-Koch C; Arnold R Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116 [TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?]. Müller-Lissner S Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693 [TBL] [Abstract][Full Text] [Related]
8. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis. Koop H; Arnold R Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654 [TBL] [Abstract][Full Text] [Related]
9. Lansoprazole versus omeprazole in the treatment of reflux esophagitis. Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117 [TBL] [Abstract][Full Text] [Related]
10. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463 [TBL] [Abstract][Full Text] [Related]
11. The role of omeprazole in healing and prevention of reflux disease. Klinkenberg-Knol EC Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392 [TBL] [Abstract][Full Text] [Related]
13. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group. Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694 [TBL] [Abstract][Full Text] [Related]
14. Reflux esophagitis: healed! Now what? Romero Y; Egan LJ; Murray JA Am J Gastroenterol; 2000 Feb; 95(2):337-8. PubMed ID: 10685730 [No Abstract] [Full Text] [Related]
15. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis]. Lauritsen K; Laursen LS; Madsen JR Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093 [No Abstract] [Full Text] [Related]
16. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy. Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066 [TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451 [TBL] [Abstract][Full Text] [Related]
18. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring. Ladas SD; Tassios PS; Raptis SA Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738 [TBL] [Abstract][Full Text] [Related]